These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 31694342)
21. Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1. Thomas L; Mautner VF; Cooper DN; Upadhyaya M Hum Genomics; 2012 Sep; 6(1):18. PubMed ID: 23244685 [TBL] [Abstract][Full Text] [Related]
22. Association of plexiform and diffuse neurofibromas with malignant peripheral nerve sheath tumor in NF I patients: a whole-body MRI assessment. Attia S; Guirguis M; Le LQ; Chhabra A Skeletal Radiol; 2024 Apr; 53(4):769-777. PubMed ID: 37903998 [TBL] [Abstract][Full Text] [Related]
23. Ganglioneuroblastoma in a Child With Neurofibromatosis Type 1: A Case Report and Literature Review. Okonta VN; Majlessipour F; Baca NM J Pediatr Hematol Oncol; 2023 Jan; 45(1):e131-e134. PubMed ID: 35398860 [TBL] [Abstract][Full Text] [Related]
24. Association between benign and malignant peripheral nerve sheath tumors in NF1. Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787 [TBL] [Abstract][Full Text] [Related]
29. Lymphocyte Subpopulations in Patients With Neurofibromatosis Type 1-associated Optic Pathway Gliomas and Plexiform Neurofibromas. Marjanska A; Kubicka M; Kurylo-Rafinska B; Jatczak-Gaca A; Wysocki M; Styczynski J Anticancer Res; 2019 Nov; 39(11):6389-6392. PubMed ID: 31704872 [TBL] [Abstract][Full Text] [Related]
30. [Role of non-coding RNA ANRIL in the genesis of plexiform neurofibromas in neurofibromatosis type 1]. Dereure O Ann Dermatol Venereol; 2012 May; 139(5):421-2. PubMed ID: 22578354 [No Abstract] [Full Text] [Related]
31. Co-occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2. Peces R; Mena R; Martín Y; Hernández C; Peces C; Tellería D; Cuesta E; Selgas R; Lapunzina P; Nevado J Mol Genet Genomic Med; 2020 Aug; 8(8):e1321. PubMed ID: 32533764 [TBL] [Abstract][Full Text] [Related]
32. Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1. Freret ME; Gutmann DH J Neurosci Res; 2019 Jan; 97(1):45-56. PubMed ID: 29704429 [TBL] [Abstract][Full Text] [Related]
33. Molecular profiles of neurofibromatosis type 1-associated plexiform neurofibromas: identification of a gene expression signature of poor prognosis. Lévy P; Bièche I; Leroy K; Parfait B; Wechsler J; Laurendeau I; Wolkenstein P; Vidaud M; Vidaud D Clin Cancer Res; 2004 Jun; 10(11):3763-71. PubMed ID: 15173083 [TBL] [Abstract][Full Text] [Related]
34. Clinical signs and genetic evaluation of patients with neurofibromatosis type 1 with and without optic pathway gliomas in a center in Turkey. Sharafi P; Varan A; Ersoy-Evans S; Ayter S Childs Nerv Syst; 2024 Feb; 40(2):511-515. PubMed ID: 37401974 [TBL] [Abstract][Full Text] [Related]
35. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1. Friedrich RE; Keiner D; Hagel C Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826 [TBL] [Abstract][Full Text] [Related]